DJS Law Group says Insulet investors may join securities class action
DJS Law Group says Insulet investors who bought shares during a stated class period may contact the firm about a securities class action tied to alleged misleading statements and manufacturing-control failures.
DJS Law Group says Insulet investors who bought shares during a stated class period may contact the firm about a securities class action tied to alleged misleading statements and manufacturing-control failures.
DJS Law Group said in a PR Newswire release dated Aug. 21, 2026, that it is reminding investors about a class action lawsuit against Insulet Corporation, the medical device maker listed on Nasdaq under the ticker PODD. The release says the complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5.
According to the release, investors who purchased PODD shares from Feb. 21, 2025, to May 26, 2026, may contact the firm about possible lead plaintiff appointments. It also says serving as lead plaintiff is not required to take part in any recovery.
The release’s summary of the complaint says Insulet allegedly made false and misleading statements to the market and failed to maintain appropriate controls over its manufacturing processes. It says those manufacturing problems created safety risks for customers and that the company’s public statements were false and materially misleading throughout the class period.
Insulet is identified in the release as the company named in the lawsuit, but the PR Newswire item does not include a response from Insulet. The release also contains promotional background about DJS Law Group and names David Schwartz as a founding partner of Schall Brown & Schwartz LLP, though those details are not independently verified in the source material provided.
The release says shareholders in the stated class period are being urged to contact the firm regarding their rights. No court ruling is described in the source material, and the item does not say when any further case deadlines are expected.
Sources
Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.
View the Web StoryA visual, tap-through version of this reportThis is the AMP version of the article. Read the full article on Atlas Watchline.